Review Papers Claim by Claim

What the paper does well

• Comprehensive, up-to-date narrative (to 2020) that integrates human, veterinary and environmental literature and practical control measures; useful One‑Health framing for surveillance and prevention (Dixon 2021 One Health).
• Clear listing of diagnostic targets and standardized methods (USEPA Method 1623, ISO 18744) relevant to environmental and food testing; highlights limits of viability assays and need for better infectivity metrics (Dixon 2021 methods).

Key limitations, blind spots & critical appraisal

• The article is a narrative review (no new primary data); thus conclusions depend on the quality and reporting of cited studies — risk of reporting/publication bias and heterogeneous methods across studies is acknowledged by the author (Dixon 2021 limitations).
• Evidence for zoonotic transmission remains equivocal: the paper correctly flags that shared assemblages (A/B) across humans and animals do not by themselves confirm direct zoonotic transmission and stresses need for high-resolution genomic tracing and better-designed source attribution studies (Dixon 2021 zoonosis caution).
• Discussion of viability/infectivity assays is correct but limited by lack of practical, validated field-ready assays — the review highlights this as a major gap (affects risk assessment and food/water surveillance quality) (Dixon 2021 viability gap).

Concrete, evidence‑based recommendations (from the paper + critical amplification)

1. Adopt standardized multi-locus and whole-genome approaches for outbreak source tracing; deposit reference genomes across all assemblages to reduce genotyping discordance (paper recommends this and provides rationale) (Dixon 2021 genomics recommendation).
2. Prioritize development/validation of viability assays correlated with infectivity (animal models or validated surrogate markers) so surveillance yields actionable risk estimates — a central gap highlighted by Dixon (Dixon 2021 viability need).
3. Implement integrated One‑Health surveillance linking human clinical isolates with animal and environmental genomes, and include metadata (location, date, exposure) to allow genomic epidemiology — aligns with the author’s final recommendations (Dixon 2021 One Health).

What would overturn the paper’s central public‑health emphasis?

The author’s priority claims (significant role for waterborne/person-to-person transmission; unclear zoonotic contribution; critical need for molecular surveillance) would be overturned by robust, multisite genomic source‑attribution studies that: (1) consistently link human cases to specific animal reservoirs with near-identical WGS isolates and epidemiological tracing, and (2) demonstrate negligible person-to-person and waterborne transmission in multiple contexts — neither exists now (paper notes that such evidence is lacking) (Dixon 2021 falsifiability note).

Immediate research actions to improve the field (concise)

• Create an international, annotated WGS reference panel for G. duodenalis assemblages A–H with standardized metadata and QC.
• Validate a field‑deployable viability/infectivity assay (mRNA + capsid/structural integrity + excystation correlation) against animal infectivity outcomes.
• Design prospective One‑Health cohort studies (paired human, animal, water, food sampling) using harmonized multi-locus and WGS pipelines to quantify reservoir contributions.